Home › Oropharyngeal Cancer › Oregon › Portland
Oropharyngeal Cancer clinical trials in Portland, OR
4 studies for Oropharyngeal Cancer are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
RecruitingPhase 4
- OHSU Knight Cancer Institute, Portland
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RecruitingPhase 3
- Providence Portland Medical Center, Portland
Oropharyngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Edison, NJ8 studies
- Chicago, IL7 studies
- New York City, NY6 studies
- Queens, NY5 studies
- St. Louis, MO5 studies
- Tampa, FL5 studies
- Kansas City, MO5 studies
- Philadelphia, PA5 studies
- Milwaukee, WI5 studies
- Omaha, NE5 studies
- Pittsburgh, PA5 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.